Item 5.02(e). Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 18, 2009, the Board of Directors of VNUS Medical Technologies, Inc.
(the "Company") approved the amendment and restatement of the Company's Amended
and Restated VNUS Severance Plan for Management and Key Employees (the "Amended
Severance Plan"). The Amended Severance Plan increases the payments due to the
Chief Executive Officer of the Company upon a qualifying termination (i) within
the first year following a change of control, from 100% to 200% of base salary
and bonus and (ii) between one and two years following a change of control, from
67% to 100% of base salary and bonus.
A copy of the Amended Severance Plan is filed as Exhibit 10.1 to this Current
Report on Form 8-K and is incorporated by reference herein.